These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 10908734
21. Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism. Hughes NR, McKnight AT, Woodruff GN, Hill MP, Crossman AR, Brotchie JM. Mov Disord; 1998 Mar; 13(2):228-33. PubMed ID: 9539334 [Abstract] [Full Text] [Related]
23. Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Takekoshi K, Ishii K, Nanmoku T, Shibuya S, Kawakami Y, Isobe K, Nakai T. Endocrinology; 2001 Nov; 142(11):4861-71. PubMed ID: 11606454 [Abstract] [Full Text] [Related]
24. Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro. Rossi NF, Kim JK, Summers SN, Schrier RW. Life Sci; 1997 Nov; 61(23):2271-82. PubMed ID: 9408050 [Abstract] [Full Text] [Related]
25. Adenosine 3',5'-cyclic monophosphate-stimulated Ca++ efflux and acetylcholine release in ileal myenteric plexus are mediated by N-type Ca++ channels: inhibition by the kappa opioid receptor agonist. Kojima Y, Tsunoda Y, Owyang C. J Pharmacol Exp Ther; 1997 Jul; 282(1):403-9. PubMed ID: 9223581 [Abstract] [Full Text] [Related]
26. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. Raynor K, Kong H, Hines J, Kong G, Benovic J, Yasuda K, Bell GI, Reisine T. J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192 [Abstract] [Full Text] [Related]
28. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. Kong H, Raynor K, Yano H, Takeda J, Bell GI, Reisine T. Proc Natl Acad Sci U S A; 1994 Aug 16; 91(17):8042-6. PubMed ID: 8058754 [Abstract] [Full Text] [Related]
29. Effect of urotensin II on PC12 rat pheochromocytoma cells. Aita Y, Kasahara T, Isobe K, Kawakami Y, Takekoshi K. J Neuroendocrinol; 2010 Feb 16; 22(2):83-91. PubMed ID: 20025629 [Abstract] [Full Text] [Related]
32. Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord. Kohno T, Kumamoto E, Higashi H, Shimoji K, Yoshimura M. J Physiol; 1999 Aug 01; 518 ( Pt 3)(Pt 3):803-13. PubMed ID: 10420016 [Abstract] [Full Text] [Related]
33. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck KO, Murray RD, Simon M. Br J Pharmacol; 1994 Dec 01; 113(4):1317-27. PubMed ID: 7889287 [Abstract] [Full Text] [Related]
34. Potential mechanisms responsible for chlorotriazine-induced alterations in catecholamines in pheochromocytoma (PC12) cells. Das PC, McElroy WK, Cooper RL. Life Sci; 2003 Oct 31; 73(24):3123-38. PubMed ID: 14550852 [Abstract] [Full Text] [Related]
35. Ca(2+) mobilization, tyrosine hydroxylase activity, and signaling mechanisms in cultured porcine adrenal medullary chromaffin cells: effects of leptin. Takekoshi K, Ishii K, Kawakami Y, Isobe K, Nanmoku T, Nakai T. Endocrinology; 2001 Jan 31; 142(1):290-8. PubMed ID: 11145592 [Abstract] [Full Text] [Related]
39. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices. Heijna MH, Padt M, Hogenboom F, Schoffelmeer AN, Mulder AH. Neuroendocrinology; 1991 Aug 31; 54(2):118-26. PubMed ID: 1662785 [Abstract] [Full Text] [Related]